More Reason To Quit: Smoking Causes Arthritis Among Blacks

By ACSH Staff — Dec 02, 2010
If there weren’t already enough reasons for cigarette smokers to quit, more incentive just appeared in the form of a longitudinal study published in the December issue of Arthritis & Rheumatism. The report demonstrated that Blacks who smoke face a dramatically increased likelihood of developing rheumatoid arthritis (RA). Further, the more smokers light up, the greater the risk.

If there weren’t already enough reasons for cigarette smokers to quit, more incentive just appeared in the form of a longitudinal study published in the December issue of Arthritis & Rheumatism. The report demonstrated that Blacks who smoke face a dramatically increased likelihood of developing rheumatoid arthritis (RA). Further, the more smokers light up, the greater the risk.

Breast milk sharing: Not the crème de la crème of baby nourishment

By ACSH Staff — Dec 02, 2010
Reuters reports that U.S. health officials have stepped up warnings to new mothers about the risks associated with the increasingly popular trend of sharing unscreened breast milk offered through internet sources, such as Eats on Feets. Health officials are instead encouraging mothers seeking breast milk for their infants to either switch to formula or ask their physician about using breast milk from certified human milk banks.

Reuters reports that U.S. health officials have stepped up warnings to new mothers about the risks associated with the increasingly popular trend of sharing unscreened breast milk offered through internet sources, such as Eats on Feets. Health officials are instead encouraging mothers seeking breast milk for their infants to either switch to formula or ask their physician about using breast milk from certified human milk banks.

Would boost to universal HIV testing initiate an infectious benefit for U.S. public health?

By ACSH Staff — Dec 02, 2010
Faced with 56,000 new HIV infections each year, the CDC proposed in 2006 that HIV testing become part of the routine evaluation that patients would receive unless they opt out — but more than half of America’s high-risk population is still unaware of their HIV status, Reuters reports.

Faced with 56,000 new HIV infections each year, the CDC proposed in 2006 that HIV testing become part of the routine evaluation that patients would receive unless they opt out — but more than half of America’s high-risk population is still unaware of their HIV status, Reuters reports.

Cancer risk from CT scans overblown

By ACSH Staff — Dec 02, 2010
A new study lessens concerns that radiation exposure from diagnostic CT scans — a medical procedure that has become more common in the past decade — has substantially increased cancer incidence.

A new study lessens concerns that radiation exposure from diagnostic CT scans — a medical procedure that has become more common in the past decade — has substantially increased cancer incidence.

Senate passes Food Safety and Modernization Act: Yea or Nay?

By ACSH Staff — Dec 01, 2010
By a vote of 73 to 25, the Senate yesterday passed the Food Safety and Modernization Act. The bill, which was opposed by TV news commentator and Tea Party activist Glenn Beck, among others, will now be up for consideration by the House of Representatives. The bill would give the FDA the power to mandate food recalls — authority it has not previously possessed. Its stated aim is to improve procedures assuring food safety.

By a vote of 73 to 25, the Senate yesterday passed the Food Safety and Modernization Act. The bill, which was opposed by TV news commentator and Tea Party activist Glenn Beck, among others, will now be up for consideration by the House of Representatives. The bill would give the FDA the power to mandate food recalls — authority it has not previously possessed. Its stated aim is to improve procedures assuring food safety.

Measurements of children s medicines are unreliable careful that the spoonful is lovin

By ACSH Staff — Dec 01, 2010
A new study appearing in today’s issue of JAMA, which examines 200 commonly-sold liquid non-prescription (OTC) medications for children, suggests that there is a serious problem of mislabeling with respect to dosage. In many cases, the study’s authors say, the dosage instructions on the label do not match the dosage measurements produced by using the product’s cap.

A new study appearing in today’s issue of JAMA, which examines 200 commonly-sold liquid non-prescription (OTC) medications for children, suggests that there is a serious problem of mislabeling with respect to dosage. In many cases, the study’s authors say, the dosage instructions on the label do not match the dosage measurements produced by using the product’s cap.

Vitamin D & calcium supplements: Less is more?

By ACSH Staff — Dec 01, 2010
Celebrity Vitamin D advocate Gwyneth Paltrow may (or may not) have a legitimate deficiency of the nutrient, but the notion of a pervasive problem of vitamin D and calcium deficiency in U.S.

Celebrity Vitamin D advocate Gwyneth Paltrow may (or may not) have a legitimate deficiency of the nutrient, but the notion of a pervasive problem of vitamin D and calcium deficiency in U.S.

Treating indolent prostate tumors: How far to go?

By ACSH Staff — Dec 01, 2010
FDA hearings begin today on the possibility of expanding the list of approved uses for Avodart and Proscar, two drugs widely prescribed to shrink enlarged prostates. This treatment relieves annoying urinary symptoms in men with BPH — benign prostatic hypertrophy.

FDA hearings begin today on the possibility of expanding the list of approved uses for Avodart and Proscar, two drugs widely prescribed to shrink enlarged prostates. This treatment relieves annoying urinary symptoms in men with BPH — benign prostatic hypertrophy.

The biggest AIDS story: How drug company scientists transformed the disease

By ACSH Staff — Dec 01, 2010
In an op-ed in today’s New York Post, ACSH’s Dr. Josh Bloom comments on what should be especially noted this World AIDS Day — the success drug company researchers have had in developing anti-retroviral drugs to treat HIV and AIDS:

In an op-ed in today’s New York Post, ACSH’s Dr. Josh Bloom comments on what should be especially noted this World AIDS Day — the success drug company researchers have had in developing anti-retroviral drugs to treat HIV and AIDS: